Literature DB >> 6136545

Changes in cell-surface expression of MHC and Thy-1.2 determinants following treatment with lipid modulating agents.

C P Muller, D A Stephany, M Shinitzky, J R Wunderlich.   

Abstract

Treatment of normal mouse spleen cells with lipid fluidity modulators changes the expression of cell-surface H-2 determinants. BALB/c spleen cells treated for 1 to 2 hr with cholesteryl hemisuccinate (CHS) displayed reduced levels of all tested H-2 determinants (H-2L, H-2K, and H-2D) as evaluated by flow microfluorometry and increased membrane lipid packing density as determined by 1,6-diphenyl-1,3,5-hexatriene (DPH) fluorescence polarization. In contrast, decreasing membrane lipid packing density by phosphatidylcholine treatment decreased DPH fluorescence polarization and increased the expression of MHC determinants. The effects were selective in that expression of Thy-1.2 determinants was decreased by the latter treatment and not increased by CHS. The results are discussed in terms of passive modulation of antigenic expression.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136545

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Authors:  Subha Banerjee; June Ghosh; Subha Sen; Rajan Guha; Ranjan Dhar; Moumita Ghosh; Sanchita Datta; Bikramjit Raychaudhury; Kshudiram Naskar; Arun Kumar Haldar; C S Lal; K Pandey; V N R Das; Pradeep Das; Syamal Roy
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

2.  Promotion of tumor antigenicity in EL-4 leukemia cells by hydrostatic pressure.

Authors:  L Richert; A Or; M Shinitzky
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers.

Authors:  P Sanderson; P C Calder
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

4.  Polymorphic and autoreactive H-2-specific monoclonal antibody isolated after injections of syngeneic Sendai virus-coated lymphocytes.

Authors:  A Opolski; F Kievits; P Iványi
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

5.  Dietary Intake and Serum Selenium Levels Influence the Outcome of HTLV-1 Infection.

Authors:  Effat Saghi; Abdolreza Norouzy; Mohsen Nematy; Lida Jarahi; Reza Boostani; Fariba Zemorshidi; Zohreh Vahidi; Houshang Rafatpanah
Journal:  Biol Trace Elem Res       Date:  2020-11-09       Impact factor: 3.738

Review 6.  Polyunsaturated fatty acids and membrane organization: elucidating mechanisms to balance immunotherapy and susceptibility to infection.

Authors:  Saame Raza Shaikh; Michael Edidin
Journal:  Chem Phys Lipids       Date:  2008-02-23       Impact factor: 3.329

7.  In vivo test of the vertical phase separation hypothesis: the display of major histocompatibility complex (MHC) class I molecules on membranes of B cells from mice fed high-fat diets.

Authors:  Saame Raza Shaikh; Sarah Boyle; Jing Hua; Zhiping Li; Michael Edidin
Journal:  Br J Nutr       Date:  2009-03       Impact factor: 3.718

8.  Enhancement of the antigen-presenting function of monocytes by cholesterol: possible relevance to inflammatory mechanisms in extrinsic allergic alveolitis and atherosclerosis.

Authors:  D A Hughes; P J Townsend; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

9.  Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking.

Authors:  V Ramakrishna; A Eisenthal; Y Skornick; M Shinitzky
Journal:  Cancer Immunol Immunother       Date:  1993-05       Impact factor: 6.968

10.  Inhibition of lymphocyte proliferation by free fatty acids. III. Modulation of thymus-dependent immune responses.

Authors:  S Pourbohloul; G S Mallett; T M Buttke
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.